An approach to fertility preservation in prepubertal and postpubertal females: A critical review of current literature

Pediatric Blood and Cancer

Volumn 62, Issue 6, 2015, Pages 935-939

  Knight, Samantha ^a   Lorenzo, Armando ^a   Maloney, Anne Marie ^a   Srikanthan, Amirrtha ^b   Donen, Rachel ^a   Greenblatt, Ellen ^c   Gupta, Abha ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Fertility preservation; Infertility; Pediatric cancer survivor; Pediatric oncology; Prepubertal females

Indexed keywords

ADULTHOOD; CANCER THERAPY; CRYOPRESERVATION; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILITY PRESERVATION; FINANCIAL MANAGEMENT; HEALTH CARE PERSONNEL; HUMAN; ONCOLOGIST; OOCYTE; OVARY INSUFFICIENCY; PRACTICE GUIDELINE; PREPUBERTY; PRIORITY JOURNAL; REVIEW; WELLBEING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; NEOPLASMS; OVARY; PATHOPHYSIOLOGY; PUBERTY;

CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASMS; OVARY; PUBERTY;

EID: 84927911040     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25440     Document Type: Review

References (73)

1. Zebrack BJ, Casillas J, Nohr L, Adams H, Zeltzer LK. Fertility issues for young adult survivors of childhood cancer. Psychooncology 2004; 13:689-699.
2. Anderson RA, Themmen APN, Al-Qahtani A, Groome NP, Cameron DA. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 2006; 21:2583.
3. Bath LE, Wallace WHB, Critchley HOD. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG 2002; 109:107-114.
4. Schover LR. Rates of postcancer parenthood. J Clin Oncol 2009; 27:321-322.
5. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31:2500-2510.
6. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001; 7:535-543.
7. Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys 2009; 73:1304-1312.
8. Lawrenz B, Rothmund R, Neunhoeffer E, Huebner S, Henes M. Fertility preservation in prepubertal girls prior to chemotherapy and radiotherapy - Review of the literature. J Pediatr Adolesc Gynecol 2012; 25:284-288.
9. Dillon KE, Gracia CR. Pediatric and young adult patients and oncofertility. Curr Treat Options Oncol 2012; 13:161-173.
10. Familiari G, Caggiati A, Nottola SA, Ermini M, Di Benedetto MR, Motta PM. Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum Reprod 1993; 8:2080-2087.
11. Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, Donaldson SS, Byrne J, Robison LL. Fertility of female survivors of childhood cancer: A report from the childhood cancer survivor study. J Clin Oncol 2009; 27:2677-2685.
12. Meirow D, Dor J, Kaufman B, Shrim A, Rabinovici J, Schiff E, Raanani H, Levron J, Fridman E. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod 2007; 22:1626-1633.
13. Meirow D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. Leuk Lymphoma 1999; 33:65-76.
14. Maltaris T, Seufert R, Fischl F, Schaffrath M, Pollow K, Koelbl H, Dittrich R. The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol 2007; 130:148-155.
15. Couto-Silva AC, Trivin C, Thibaud E, Esperou H, Michon J, Brauner R. Factors affecting gonadal function after bone marrow transplantation during childhood. Bone Marrow Transplant 2001; 28:67-75.
16. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum FR. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87:3045-3052.
17. Jackson GHG, Wood AA, Taylor PRA, Lennard AL, Lucraft H, Heppleston A, Robinson P, Moore J, Proctor SJ. Early high dose chemotherapy intensification with autologous bone marrow transplantation in lymphoma associated with retention of fertility and normal pregnancies in females. Scotland and Newcastle Lymphoma Group, UK. Leuk Lymphoma 1997; 28:127-132.
18. Metzger ML, Meacham LR, Patterson B, Casillas JS, Constine LS, Hijiya N, Kenney LB, Leonard M, Lockart BA, Likes W, Green DM. Female reproductive health after childhood, adolescent, and young adult cancers: Guidelines for the assessment and management of female reproductive complications. J Clin Oncol 2013; 31:1239-1247.
19. Chiarelli AM, Marrett LD, Darlington G. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada. Am J Epidemiol 1999; 150:245-254.
20. Sklar C. Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monographs 2005; 34:25-27.
21. Group CO. Long-Term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. CureSearch Version 4, 2013:1-222.
22. Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, Robison LL, Sklar CA. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 2006; 91:1723-1728.
23. Wallace WHB, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: Who is at risk and what can be offered. Lancet Oncol 2005; 6:209-218.
24. Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, Holmes GF, Holmes FF, Latourette HB, Meigs JW, Strong LC, Myers MH, Mulvihill JJ. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 1992; 166:788-793.
25. Lantinga GM, Simons AHM, Kamps WA, Postma A. Imminent ovarian failure in childhood cancer survivors. Eur J Cancer 2006; 42:1415-1420.
26. Silva ARE, Silva JRE, Reis RM. Gonadal function in adolescent patients submitted to chemotherapy during childhood or during the pubertal period. J Pediatr Adolesc Gynecol 2007; 20:89-91.
27. de Vet A, Laven JSE, de Jong FH. Themmen AP, Fauser BC. Antimüllerian hormone serum levels: A putative marker for ovarian aging. Fertil Steril 2002; 77:357-362.
28. Sowers MR, Eyvazzadeh AD, McConnell D, Yosef M, Jannausch ML, Zhang D, Harlow S. Randolph JF Jr. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008; 93:3478-3483.
29. Tehrani FR, Solaymani-Dodaran M, Azizi F. A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause 2009; 16:797-802.
30. Broer SL, Eijkemans MJC, Scheffer GJ, van Rooiji IA, de Vet A, Themmen AP, Laven JS, de Jong FH, Te Velde ER, Frauser BC, Broekmans FJ. Anti-mullerian hormone predicts menopause: A long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab 2011; 96:2532-2539.
31. Freeman EW, Sammel MD, Lin H, Gracia CR. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab 2012; 97:1673-1680.
32. Lutchman Singh, Muttukrishna K, Stein S, McGarrigle RC, Patel HH, Parikh A, Groome B, Davies NP, Chatterjee MC. Predictors of ovarian reserve in young women with breast cancer. Br J Cancer 2007; 96:1808-1816.
33. Lie Fong, Lugtenburg S, Schipper PJ, Themmen I, de Jong AP, Sonneveld FH, Laven P. Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod 2008; 23:674-678.
34. Bath LE, Wallace WHB, Shaw MP, Fitzpatrick C, Anderson RA. Depletion of ovarian reserve in young women after treatment for cancer in childhood: Detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003; 18:2368-2374.
35. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online 2009; 18:769-776.
36. Lobo RA. Potential options for preservation of fertility in women. N Engl J Med 2005; 353:4-73.
37. Koch J, Ledger W. Ovarian stimulation protocols for onco-fertilty patients. J Assist Reprnet 2013; 30:203-206.
38. Vadaparampil S, Quinn G, King L, Wilson C, Nieder M. Barriers to fertility preservation among pediatric oncologists. Patient Educ Couns 2008; 72:402-410.
39. Dudzinski DM. Ethical issues in fertility preservation for adolescent cancer survivors: Oocyte and ovarian tissue cryopreservation. J Pediatr Adolesc Gynecol 2004; 17:97-102.
40. Andrieu JM, Ochoa-Molina ME. Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease. Cancer 1983; 52:435-438.
41. Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer 1999; 86:697-709.
42. Oktay K. Ovarian tissue cryopreservation and transplantation: Preliminary findings and implications for cancer patients. Hum Reprod Update 2001; 7:526-534.
43. Donnez J, Dolmans MM. Preservation of fertility in females with haematological malignancy. Br J Haematol 2011; 154:175-184.
44. Bastings L, Beerendonk CCM, Westphal JR, Massuger LFAG, Kaal SEJ, van Leeuwen FE, Braat DDM, Peek R. Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: A systematic review. Hum Reprod Update 2013; 19:483-506.
45. Dolmans MM, Jadoul P, Gilliaux S, Amorim CA, Luyckx V, Squifflet J, Donnez J, Van Langendonckt A. A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet 2013; 30:305-314.
46. Woodruff TK. The Oncofertility Consortium - Addressing fertility in young people with cancer. Nat Rev Clin Oncol 2010.
47. Donnez J, Godin PA, Qu J, Nisolle M. Gonadal cryopreservation in the young patient with gynaecological malignancy. Curr Opin Obstet Gynecol 2000; 12:1-9.
48. Dolmans MM, Marinescu C, Saussoy P, Van Langendockt A, Amorim C, Donnez J. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood 2010; 116:2908-2914.
49. Dolmans MM, Marotta ML, Pirard CL, Donnez J, Donnez O. Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes. J Ovarian Res 2014; 7:80.
50. Peate M, Meiser B, Friedlander M, Zorbas H, Roveli S, Sansom-Daly U. Fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer - An Australian fertility decision aid collaborative. J Clin Oncol 2011; 29:1670-1677.
51. Rosoff PM, Katsur ML. Preserving fertility in young cancer patients: A medical, ethical and legal challenge. J Philos Sci Law 2003. www.psljournal.com/archives/papers/preservingFert.cfm.
52. Greil AL. Infertility and psychological distress: A critical review of the literature. Soc Sci Med 1997; 45:1679-1704.
53. Schover LR. Psychosocial aspects of infertility and decisions about reproduction in young cancer survivors: A review. Med Pediatr Oncol 1999; 33:53-59.
54. Singh S, Katoch VM. Commercial serological tests for the diagnosis of active tuberculosis in India: Time for introspection. Indian J Med Res 2011; 134:583-587.
55. Cohen CB. Some perils of "waiting to be born": Fertility preservation in girls facing certain treatments for cancer. Am J Bioeth 2008; 8:30-32.
56. Quinn GP, Vadaparampil ST, Lowrey KM. State laws and regulations addressing third-party reimbursement for infertility treatment: Implications for cancer survivors. Fertil Steril 2011; 95:72-78.
57. Campo-Engelstein L. For the sake of consistency and fairness: Why insurance companies should cover fertility preservation treatment for iatrogenic infertility. Cancer Treat Res 2010; 156:381-388.
58. Basco D, Campo-Engelstein L, Rodriguez S. Insuring against infertility: Expanding state infertility mandates to include fertility preservation technology for cancer patients. J Law Med Ethics 2010; 38:832-839.
59. Meirow D, Fasouliotis SJ, Nugent D, Schenker JG, Gosden RG, Rutherford AJ. A laparoscopic technique for obtaining ovarian cortical biopsy specimens for fertility conservation in patients with cancer. Fertil Steril 1999; 71:948-951.
60. Fallat ME, Hutter J, American Academy of Pediatrics Committee on Bioethics, American Academy of Pediatrics Section on Hematology/Oncology, American Academy of Pediatrics Section on Surgery. Preservation of fertility in pediatric, adolescent patients with cancer. Pediatrics 2008; 121:e1461-e1469.
61. Thomas Toth, Vincent MD. Reproductive Endocrinology Service. Boston, MA: Massachusetts General Hospital; 2006.
62. Oktay K. Fertility preservation: An emptying discipline in the care of young patients with cancer. Lancet Oncol 2005; 6:192-193.
63. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24:2917-2931.
64. Rosen A, Rodriguez-Wallberg KA, Rosenzweig L. Psychosocial distress in young cancer survivors. Semin Oncol Nurs 2009; 25:268-277.
65. Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol 2002; 20:1880-1889.
66. Balthazar U, Fritz MA, Mersereau JE. Fertility preservation: A pilot study to assess previsit patient knowledge quantitatively. Fertil Steril 2011; 95:1913-1916.
67. Crawshaw MA, Sloper P. "Swimming against the tide"- The influence of fertility matters on the transition to adulthood or survivorship following adolescent cancer. Eur J Cancer Care 2010; 19:610-620.
68. Wallace WH. Fertility preservation for young people treated with cancer: What are the attitudes and knowledge of clinicians. Pediatr Blood Cancer 2007; 48:2-3.
69. Vadaparampil ST, Clayton H, Quinn GP, King LM, Nieder M, Wilson C. Pediatric oncology nurses' attitudes related to discussing fertility preservation with pediatric cancer patients and their families. J Pediatr Oncol Nurs 2007; 24:255-263.
70. Goodwin T, Elizabeth Oosterhuis, Kiernan B, Hudson M, Dahl MM. Attitudes and practices of pediatric oncology providers regarding fertility issues. Pediatr Blood Cancer 2007; 48:80-85.
71. Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S. Oncologists' attitudes and practices regarding banking sperm before cancer treatment. J Clin Oncol 2002; 20:1890-1897.
72. Achille MA, Rosberger Z, Robitaille R, Lebel S, Gouin JP, Bultz BD, Chan PT. Facilitators and obstacles to sperm banking in young men receiving gonadotoxic chemotherapy for cancer: The perspective of survivors and health care professionals. Hum Reprod 2006; 21:3206-3216.
73. Loren AW, Brazauskas R, Chow EJ, Gilleece M, Halter J, Jacobsohn DA, Joshi S, Pidala J, Quinn GP, Wang Z, Apperley JF, Burns LJ, Hale GA, Hayes-Lattin BM, Kamble R, Lazarus H, McCarthy PL, Reddy V, Warwick AB, Bolwell BJ, Duncan C, Socie G, Sorror ML, Wingard JR, Majhail NS. Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant 2013; 48:1091-1097.